{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,15]],"date-time":"2026-04-15T23:47:35Z","timestamp":1776296855169,"version":"3.50.1"},"reference-count":28,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2021,11,1]],"date-time":"2021-11-01T00:00:00Z","timestamp":1635724800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,11,1]],"date-time":"2021-11-01T00:00:00Z","timestamp":1635724800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","rbmojournal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Reproductive BioMedicine Online"],"published-print":{"date-parts":[[2021,11]]},"DOI":"10.1016\/j.rbmo.2021.08.022","type":"journal-article","created":{"date-parts":[[2021,8,30]],"date-time":"2021-08-30T11:32:55Z","timestamp":1630323175000},"page":"864-870","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"title":["Levonorgestrel-releasing intrauterine system versus oral medroxyprogesterone acetate in infertile women with endometrial hyperplasia without atypia"],"prefix":"10.1016","volume":"43","author":[{"given":"Giovanni","family":"Campo","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Agnese","family":"Rebecchi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Valeria S.","family":"Vanni","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Luca","family":"Pagliardini","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Carola","family":"Patruno","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Enrico","family":"Papaleo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Massimo","family":"Candiani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Paolo","family":"Giardina","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"4","key":"10.1016\/j.rbmo.2021.08.022_bib0001","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1016\/j.ajog.2015.03.037","article-title":"Levonorgestrel-releasing intrauterine system vs oral progestins for non-atypical endometrial hyperplasia: a systematic review and meta-analysis of randomized trials","volume":"213","author":"Abu Hashim","year":"2015","journal-title":"Am. J. Obstet. Gynecol."},{"key":"10.1016\/j.rbmo.2021.08.022_bib0002","article-title":"Gonadotrophin-releasing hormone antagonists for assisted reproductive technology","volume":"4","author":"Al-Inany","year":"2016","journal-title":"Cochrane Database Syst. Rev."},{"issue":"5","key":"10.1016\/j.rbmo.2021.08.022_bib0003","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1111\/j.1600-0412.2011.01091.x","article-title":"A systematic review of gynecological cancer surveillance in women belonging to hereditary nonpolyposis colorectal cancer (Lynch syndrome) families","volume":"90","author":"Auranen","year":"2011","journal-title":"Acta Obstet. Gynecol. Scand."},{"issue":"28","key":"10.1016\/j.rbmo.2021.08.022_bib0004","doi-asserted-by":"crossref","first-page":"3661","DOI":"10.1002\/sim.6607","article-title":"Moving towards best practice when using inverse probability of treatment weighting (IPTW) using the propensity score to estimate causal treatment effects in observational studies","volume":"34","author":"Austin","year":"2015","journal-title":"Stat. Med."},{"issue":"1","key":"10.1016\/j.rbmo.2021.08.022_bib0005","doi-asserted-by":"crossref","first-page":"e8","DOI":"10.3802\/jgo.2016.27.e8","article-title":"Therapeutic options for management of endometrial hyperplasia","volume":"27","author":"Chandra","year":"2016","journal-title":"J. Gynecol. Oncol."},{"key":"10.1016\/j.rbmo.2021.08.022_bib0006","first-page":"122","article-title":"The efficacy of intrauterine versus oral progestin for the treatment of endometrial hyperplasia. A prospective randomized comparative study","volume":"40","author":"Dolapcioglu","year":"2013","journal-title":"Clin. Exp. Obstet. Gynecol."},{"issue":"3","key":"10.1016\/j.rbmo.2021.08.022_bib0007","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1177\/1933719114542014","article-title":"Levonorgestrel-releasing intrauterine device versus dydrogesterone for management of endometrial hyperplasia without atypia","volume":"22","author":"El Behery","year":"2015","journal-title":"Reprod. Sci."},{"issue":"2","key":"10.1016\/j.rbmo.2021.08.022_bib0008","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1055\/s-0034-1396256","article-title":"Uterus commission of the Gynecological Oncology Working Group (AGO). New WHO Classification of Endometrial Hyperplasias","volume":"75","author":"Emons","year":"2015","journal-title":"Geburtshilfe Frauenheilkd"},{"issue":"6","key":"10.1016\/j.rbmo.2021.08.022_bib0009","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1093\/aje\/kwn168","article-title":"Risk of complex and atypical endometrial hyperplasia in relation to anthropometric measures and reproductive history","volume":"15","author":"Epplein","year":"2008","journal-title":"Am. J. Epidemiol."},{"issue":"3","key":"10.1016\/j.rbmo.2021.08.022_bib0010","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1016\/S0002-9378(99)70487-4","article-title":"An evaluation of risk factors for endometrial hyperplasia in premenopausal women with abnormal menstrual bleeding","volume":"181","author":"Farquhar","year":"1999","journal-title":"Am. J. Obstet. Gynecol."},{"key":"10.1016\/j.rbmo.2021.08.022_bib0011","doi-asserted-by":"crossref","first-page":"175","DOI":"10.3758\/BF03193146","article-title":"G*Power 3: a flexible statistical power analysis program for the social, behavioral, and biomedical sciences","author":"Faul","year":"2007","journal-title":"Behav. Res. Methods"},{"issue":"11","key":"10.1016\/j.rbmo.2021.08.022_bib0012","doi-asserted-by":"crossref","first-page":"2966","DOI":"10.1093\/humrep\/det320","article-title":"LNG-IUS versus oral progestogen treatment for endometrial hyperplasia: a long-term comparative cohort study","volume":"28","author":"Gallos","year":"2013","journal-title":"Hum. Reprod."},{"key":"10.1016\/j.rbmo.2021.08.022_bib0013","doi-asserted-by":"crossref","first-page":"1327","DOI":"10.1093\/humrep\/des042","article-title":"Evaluating the association between endometrial cancer and polycystic ovary syndrome","volume":"27","author":"Haoula","year":"2012","journal-title":"Hum. Reprod."},{"issue":"2","key":"10.1016\/j.rbmo.2021.08.022_bib0014","doi-asserted-by":"crossref","first-page":"102","DOI":"10.3802\/jgo.2010.21.2.102","article-title":"The effectiveness of levonorgestrel releasing intrauterine system in the treatment of endometrial hyperplasia in Korean women","volume":"21","author":"Lee","year":"2010","journal-title":"J. Gynecol. Oncol."},{"issue":"5","key":"10.1016\/j.rbmo.2021.08.022_bib0015","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1016\/j.contraception.2011.04.002","article-title":"Fertility after discontinuation of contraception: a comprehensive review of the literature","volume":"84","author":"Mansour","year":"2011","journal-title":"Contraception"},{"issue":"10","key":"10.1016\/j.rbmo.2021.08.022_bib0016","doi-asserted-by":"crossref","first-page":"2103","DOI":"10.1093\/humrep\/16.10.2103","article-title":"Effects of the levonorgestrel-releasing intrauterine system on proliferation and apoptosis in the endometrium","volume":"16","author":"Maruo","year":"2001","journal-title":"Hum. Reprod."},{"issue":"6","key":"10.1016\/j.rbmo.2021.08.022_bib0017","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1111\/j.1365-2265.1982.tb01625.x","article-title":"Tissue concentrations of levonorgestrel in women using a levonorgestrel-releasing IUD","volume":"17","author":"Nilsson","year":"1982","journal-title":"Clin. Endocrinol. (Oxf.)"},{"issue":"6","key":"10.1016\/j.rbmo.2021.08.022_bib0018","doi-asserted-by":"crossref","first-page":"445","DOI":"10.5468\/ogs.2019.62.6.445","article-title":"Endometrial thickness cut-off value by transvaginal ultrasonography for screening of endometrial pathology in premenopausal and postmenopausal women","volume":"62","author":"Park","year":"2019","journal-title":"Obstet. Gynecol. Sci."},{"key":"10.1016\/j.rbmo.2021.08.022_bib0019","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1097\/AOG.0b013e3181e93330","article-title":"Complex hyperplasia with and without atypia: clinical outcomes and implications of progestin therapy","volume":"116","author":"Reed","year":"2010","journal-title":"Obstet. Gynecol."},{"issue":"3","key":"10.1016\/j.rbmo.2021.08.022_bib0020","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1097\/AOG.0b013e318198a10a","article-title":"Progestin therapy of complex endometrial hyperplasia with and without atypia","volume":"113","author":"Reed","year":"2009","journal-title":"Obstet. Gynecol."},{"issue":"1","key":"10.1016\/j.rbmo.2021.08.022_bib0021","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1016\/j.ygyno.2013.10.028","article-title":"Preventing endometrial cancer risk in polycystic ovarian syndrome (PCOS) women: could metformin help?","volume":"132","author":"Shafiee","year":"2014","journal-title":"Gynecol. Oncol."},{"issue":"3","key":"10.1016\/j.rbmo.2021.08.022_bib0022","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1097\/00004347-198609000-00005","article-title":"Endometrial morphology during long-term use of levonorgestrel-releasing intrauterine devices","volume":"5","author":"Silverberg","year":"1986","journal-title":"Int. J. Gynecol. Pathol."},{"issue":"1","key":"10.1016\/j.rbmo.2021.08.022_bib0023","doi-asserted-by":"crossref","first-page":"6888","DOI":"10.1038\/s41598-020-63798-8","article-title":"Differential Effects of the Hormonal and Copper Intrauterine Device on the Endometrial Transcriptome","volume":"10","author":"Smith-McCune","year":"2020","journal-title":"Sci. Rep."},{"issue":"9","key":"10.1016\/j.rbmo.2021.08.022_bib0024","article-title":"Endometrial hyperplasia in infertile women undergoing IVF\/ICSI: A retrospective cross-sectional study","volume":"49","author":"Tian","year":"2020","journal-title":"J. Gynecol. Obstet. Hum. Reprod."},{"issue":"2","key":"10.1016\/j.rbmo.2021.08.022_bib0025","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/j.ejogrb.2008.02.022","article-title":"The effectiveness of a levonorgestrel-releasing intrauterine system (LNG-IUS) in the treatment of endometrial hyperplasia\u2013a long-term follow-up study","volume":"139","author":"Varma","year":"2008","journal-title":"Eur. J. Obstet. Gynecol. Reprod. Biol."},{"issue":"3","key":"10.1016\/j.rbmo.2021.08.022_bib0026","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1016\/j.ygyno.2003.07.002","article-title":"Nuclear morphometric changes and therapy monitoring in patients with endometrial hyperplasia: a study comparing effects of intrauterine levonorgestrel and systemic medroxyprogesterone","volume":"91","author":"Vereide","year":"2003","journal-title":"Gynecol. Oncol."},{"issue":"2","key":"10.1016\/j.rbmo.2021.08.022_bib0027","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1016\/j.ygyno.2005.10.030","article-title":"Effect of levonorgestrel IUD and oral medroxyprogesterone acetate on glandular and stromal progesterone receptors (PRA and PRB), and estrogen receptors (ER-alpha and ER-beta) in human endometrial hyperplasia","volume":"101","author":"Vereide","year":"2006","journal-title":"Gynecol. Oncol."},{"key":"10.1016\/j.rbmo.2021.08.022_bib0028","doi-asserted-by":"crossref","DOI":"10.1097\/PAS.0b013e31802d68ce","article-title":"Histologic alterations in endometrial hyperplasia and well-differentiated carcinoma treated with progestins","author":"Wheeler","year":"2007","journal-title":"Am. J. Surg. Pathol."}],"container-title":["Reproductive BioMedicine Online"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1472648321004211?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1472648321004211?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T08:21:31Z","timestamp":1761466891000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1472648321004211"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,11]]},"references-count":28,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2021,11]]}},"alternative-id":["S1472648321004211"],"URL":"https:\/\/doi.org\/10.1016\/j.rbmo.2021.08.022","relation":{},"ISSN":["1472-6483"],"issn-type":[{"value":"1472-6483","type":"print"}],"subject":[],"published":{"date-parts":[[2021,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Levonorgestrel-releasing intrauterine system versus oral medroxyprogesterone acetate in infertile women with endometrial hyperplasia without atypia","name":"articletitle","label":"Article Title"},{"value":"Reproductive BioMedicine Online","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.rbmo.2021.08.022","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Reproductive Healthcare Ltd. Published by Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}